The relationship between alcohol intake and rectal cancer is uncertain.
C olorectal cancer (CRC) ranks third in both incidence and cancer mortality among men and women in the United States; CRC is diagnosed in approximately 150,000 people each year, and 50,000 deaths each year are attributable to CRC. 1 Rectal cancer accounts for a substantial portion of all CRC, approximately 30% of cases. 2 Optimal treatment for rectal cancer requires coordinated, multispecialty care, and is associated with higher health care utilization and costs than colon cancer. 3 In addition to differences in management, rectal cancer and colon cancer also have different risk factor profiles. 4, 5 Alcohol is a potentially modifiable risk factor that has been linked to multiple cancers of the gastrointestinal tract including oropharyngeal and squamous esophageal cancer. 6 -10 With respect to CRC, the evidence is conflicting. Previous studies have reported a weak positive association between alcohol and CRC, especially for higher alcohol intakes. 11, 12 Some studies, however, suggest an inverse relationship between alcohol and CRC, especially wine. 13, 14 The effect of beer intake on CRC is uncertain. Few studies focus on the relationship between alcohol and rectal cancer specifically. Furthermore, many studies of this association have taken place in European countries, where drinking patterns and social determinants of alcohol consumption may differ from the United States.
Utilizing data from the North Carolina Colon Cancer Study, a large population-based case-control study, we aimed to determine the association between alcohol intake and the risk of distal CRC. We were particularly interested in the effect of moderate alcohol intake and the effects of different beverages (beer, wine, and liquor) on the risk of rectal cancer.
MATERIALS AND METHODS

Study Design and Population
The North Carolina Colon Cancer Study-Phase II was a population-based case-control study of incident distal large-bowel cancer (rectal, rectosigmoid, or sigmoid cancer) in 33 counties in the central and eastern part of North Carolina. 15 These counties included urban, suburban, and rural areas and a diverse socioeconomic population. Study data were collected by trained nurse interviewers during in-person interviews. To confirm the diagnosis of invasive adenocarcinoma of the sigmoid, rectosigmoid, or rectum, pathology reports were obtained and reviewed by the study pathologist for each case. The study was designed and reported in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology guidelines. 16 
Identification of Cases and Controls
Participants (cases and controls) were eligible for the study if they were residents of the selected counties, aged between 40 and 80 years, had a North Carolina driver's license or identification card, were able to complete an interview in English, and were not deaf or hard of hearing, too ill to be interviewed, legally incompetent, or currently incarcerated.
A total of 1831 potentially eligible patients with a first diagnosis of invasive adenocarcinoma in the sigmoid, rectosigmoid, and rectum were identified through the rapid case ascertainment system of the North Carolina Central Cancer Registry between May 2001 and September 2006. 17 Of the 1831 potentially eligible cases identified, 57 (3%) were excluded for physician refusal, and 357 (19%) were found ineligible. Of the remaining 1417 eligible cases, 118 (8%) were not able to be contacted, 242 (17%) refused to participate, and 1058 (75%) completed an in-person interview. Subsequently, 25 cases were excluded because they had no data on alcohol intake, the exposure of interest.
Using a randomized recruitment technique, 18 controls without a previous diagnosis of CRC were randomly selected from North Carolina Division of Motor Vehicle records (for controls age Ͻ65) or from Health Care Financing Administration records (for controls age Ն65), based on sampling probabilities within blocks defined by sex, race, and 5-year age group. African Americans were oversampled to enhance their proportion. A total of 2345 subjects were initially identified as eligible controls, but 518 (22%) were later determined to be ineligible according to the above criteria (eg, they did not reside in the 33 county study area, etc). Of the 1827 remaining eligible controls, 325 (18%) were not able to be contacted, and 483 (26%) refused to participate. A total of 1019 (56% of eligible controls) completed an interview. Subsequently, 8 controls were excluded because they had no data on alcohol intake. This study was approved by the Institutional Review Board of the University of North Carolina, and all subjects provided written informed consent before participation.
Assessment of Main Exposure and Covariates of Interest
Information on alcohol intake was obtained during the interview. Participants were asked whether they drank beer, wine, or liquor, and the frequency and amount of consumption 1 year before diagnosis (cases) or at the time of the interview (controls). From responses to these questions, consumption of beer (ounces/day), wine (ounces/ day), and liquor (shots/day) were calculated. Alcohol intake (grams/day) was also determined from these questions. Alcoholic beverage consumption was subsequently categorized into none, moderate, and heavy intake based on accepted definitions. 19 Nonbeverage alcohol consumption (eg, trace amounts of alcohol used in cooking) was disregarded.
Data on potential confounders including nonsteroidal anti-inflammatory drug (NSAID) use, physical activity, red meat intake, smoking, and family history of colorectal cancer were also obtained in the interview. In addition to age, race, and sex, demographic information such as education, household income, and insurance status was also collected. All participants were asked their weight 1 year before diagnosis (case) or interview (control) to calculate body mass index from a weight that was unaffected by the cancer diagnosis or treatment. Physical activity was assessed via a validated 7-day physical activity recall questionnaire. 20, 21 Dietary intake was assessed via a validated Diet History Questionnaire. 22, 23 Daily intakes of nutrients and other food components (including alcohol) were calculated with DietCalc software obtained from the National Cancer Institute (http://riskfactor.cancer.gov/DHQ/dietcalc).
Statistical Analysis
Bivariate analysis of exposure variables was performed using 2 tests. Alcohol intake was examined using variables that accounted for different levels of intake, beverage type, and combination of beverages consumed. All covariates were assessed for confounding and effect measure modification. Because folate intake was felt to be a causal intermediate on the pathway from alcohol to CRC, it was not included as a covariate in multivariate analyses. 24 Multivariate logistic regression modeling was performed to estimate odds ratios (OR) and 95% confidence intervals (CIs) for the association between alcohol intake and distal CRC. All logistic regression models included indicator variables for the matching strata (determined by sex, age, and race) as well as an offset term to adjust for sampling probability. 18, 25 To determine which covariates should be included in the final multivariable models, we constructed a full model with all potential confounders, and assessed the change in ␤ coefficients for those with any vs no alcohol intake in relation to distal CRC when covariates were removed using backward elimination with a threshold of Ͻ10% change in ␤ coefficients and a likelihood ratio test P value of Ͼ.10. The final model contained the exposure (alcohol intake), educational level, smoking status, obesity, family history of colon cancer, red meat consumption, and NSAID use.
We also constructed logistic regression models for each exposure subtype of interest (eg, beer, wine, or spirits), and with a categorical exposure variable accounting for different combinations of beverages consumed. Finally, polytomous regression (using the same exposure variables) was subsequently used to evaluate whether the observed effects were similar among those with cancer of the rectum, and rectosigmoid and sigmoid colon. Because polytomous models cannot incorporate weights, the offset term was not included for these analyses. All analyses were performed with STATA version 10.1 (College Station, TX).
RESULTS
Participants
The final study population included 1033 cases and 1011 controls. Cases and controls differed significantly by age, race, red meat intake, NSAID use, education level, insurance status, and household income ( Table 1 ). Significant differences also existed between cases and controls with respect to overall alcohol intake and quantities of specific alcoholic beverages consumed. In general, cases had a higher proportion of nondrinkers and a lower proportion of moderate drinkers for beer, wine, and liquor ( Table 2) .
Primary Analyses
The OR for distal CRC for those with any alcohol intake compared with nondrinkers was 0.73 (95% CI 0.60, 0.90). We further analyzed the effect of different levels of alcohol consumption. The adjusted OR for distal CRC associated with moderate alcohol intake was 0.66 (95% CI 0.53, 0.82), indicating that the odds of distal CRC were decreased for moderate alcohol users. There was no statistically significant association between heavy alcohol use and distal CRC ( Table 3) .
Beverage Type
After adjusting for confounders, moderate beer intake was associated with an OR for distal CRC of 0.76 (95% CI 0.60, 0.96). Moderate wine intake was also inversely related to distal CRC: OR 0.69 (95% CI 0.56, 0.86). Neither heavy beer nor heavy wine intake were significantly associated with distal CRC. There were no statistically significant associations between liquor intake and CRC, although the highest level of liquor consumption (Ͼ1 shot/day) did appear to be associated with an elevated risk of CRC: OR 1.46 (95% CI 0.92, 2.36) ( Table 3) . Because of overlapping consumption of different alcoholic beverages, we sought to estimate the effects of both isolated consumption of each beverage type, and different combinations of beverages consumed. Wine intake, whenever it was included in beverage combinations, was associated with the lowest OR of CRC (for wine only: OR 0.64 (95% CI 0.45, 0.93), for wine and beer: OR 0.60 (95% CI 0.41, 0.88); and for wine, beer, and liquor: 0.74 (95% CI 0.54, 1.00)) ( Fig. 1) .
Effect of Race, Sex, and Smoking Status
When stratified by race, the OR for distal CRC associated with moderate alcohol intakes was similar for blacks and nonblacks. Similarly, males and females had similar odds of distal CRC associated with moderate intake. When stratified by smoking status, never smokers had the lowest ORs associated with moderate wine and liquor consumption, whereas current smokers had the highest ORs, but this OR heterogeneity was not statistically significant (P ϭ .6) ( Table 4 ).
Site of Cancer
Because this study included cases of distal CRC including cancers of the rectum, rectosigmoid, and sigmoid colon, we sought to estimate the ORs for each site specifically. For moderate overall alcohol intake, the OR of rectal cancer specifically was 0.69 (95% CI 0.51, 0.93). For moderate wine intake, the OR for rectal cancer was similar: 0.69 (95% CI 0.51, 0.93) ( Table 5 ). 
DISCUSSION
In this case control study, we found that alcohol use and especially wine intake was inversely associated with distal colorectal cancer. This effect was consistent for cancers of the rectum, rectosigmoid and sigmoid colon, was not modified by age, race, sex, or smoking status, and persisted after accounting for multiple potential confounding factors. The protective effect appeared confined primarily to the moderate consumption strata across alcohol types.
Some previous studies have shown a positive association between alcohol intake (particularly heavy alcohol use) and rectal cancer, in general, of fairly low magnitude. A meta-analysis of 27 studies relating consumption of alcoholic beverages to risk of colorectal cancer found a weak positive association for consumption of 2 or more alcoholic drinks (24 g) daily and rectal cancer (relative risk (RR) 1.10 (95% CI 1.02, 1.18)). 12 A pooled analysis of 8 cohort studies addressing this topic found that only high alcohol intakes (30 to Ͻ45 g/day and Ն45 g/day) were significantly associated with increased risk of rectal cancer: RR 1.42 (95% CI 1.07, 1.88) and 1.49 (95% CI 1.04, 2.12). 11 An analysis from the multicenter European Prospective Investigation into Cancer and Nutrition cohort study reported an elevated risk of rectal cancer only for those with very high average lifetime alcohol intakes: hazard ratio for those consuming (Ͼ60 g/day) compared with the lowest level of consumption was 2.59 (95% CI 1.62, 4.13). However, other studies have reported both null and inverse associations between alcohol consumption and CRC. 13, 14, 26 Nevertheless, previous reports that heavy alcohol consumption is associated with increased risk of CRC are not necessarily inconsistent with our findings.
We focused on moderate intake but also found evidence that heavy intake of alcohol may be associated with increased risk of distal CRC. Heavy alcohol consumption was relatively rare in our sample; 109 participants (5.3%) had alcohol intakes Ն45 g/day and 70 participants (3.4%) had alcohol intakes Ͼ60 g/day. Given the small numbers of heavy alcohol consumers in our study, it is certainly possible that higher levels of alcohol consumption are associated with an elevated risk of CRC. Indeed, in this study, heavy beer and liquor intakes were associated with ORs greater than 1, although they were not statistically significant. This finding points to the possibility that there may be a "J-shaped" dose-response curve for alcohol and CRC, in which moderate intakes are associated with reduced risk of CRC, but the risk increases for those with heavy use as others have postulated. 13 Our findings may also differ somewhat from previous studies because of changes in folate intake over time. Because alcohol interferes with folate metabolism, and folate has been shown to have a protective effect for CRC, [27] [28] [29] changes in folate intake could impact ORs obtained via logistic regression, adjusted for age, sex, race, red meat intake, NSAID use, family history of CRC, obesity, smoking status, and education level. P values for likelihood ratio tests for models with interaction terms for race, sex, and smoking status all Ͼ.10, indicating lack of strong effect measure modification. CRC ϭ colorectal cancer; NSAID ϭ nonsteroidal anti-inflammatory drug. the total effect of alcohol on rectal cancer. Indeed, some studies have suggested that adequate folate is a necessary precursor for a beneficial effect of alcohol in CRC. 27, 30 Since 1996, the US Food and Drug Administration has required the addition of folic acid to enriched breads, cereals, flours, corn meals, pastas, rice, and other grain products, 31 which may be one reason why some American studies conducted before the late 1990s found that alcohol was associated with an elevated risk of CRC. Several studies have reported either a null or an inverse association between wine consumption and CRC, particularly with moderate wine intake. [12] [13] [14] 32, 33 In a study of 41,837 postmenopausal women in the United States, wine consumption was found to be inversely associated with distal colon cancer: RR 0.64 (95% CI 0.40, 0.98). 14 A Danish cohort study found that wine consumption lowered the risk of rectal cancer, even in combination with other alcoholic beverages. 33 In a recent analysis from a British cohort study involving 25,639 participants, daily consumption of one or more glasses of wine was associated with a decreased risk of CRC (hazard ratio 0.61 (95% CI 0.40, 0.94). 13 Interestingly, wine intake has also been demonstrated to be inversely associated with other gastrointestinal cancers, namely gastric 34 and esophageal adenocarcinoma. 8 Apart from its relationship to cancer, moderate alcohol intake is associated with a variety of salutatory effects, such as protection from coronary heart disease, 35, 36 stroke, 37,38 diabetes, 39 dementia, 36 and even reduced overall mortality. 40 The biologic mechanism by which alcohol may mitigate the risk of cancer is unknown, but may be related to antioxidant properties. Wine, in particular, has antioxidant and antithrombotic properties related to its flavonoid and phenolic components. 41 One of these compounds, resveratrol, has been shown to have cancer chemopreventive effects. 42 This study has important strengths. We used a validated questionnaire for measurement of exposure and covariates of interest. The outcome (distal CRC) was determined via a cancer registry and was independently verified by the study team, making measurement error unlikely. In comparison with other published studies on this topic, we enrolled a relatively large number of CRC cases, and thus our statistical power allowed for more precise estimates. The population-based sampling of this study avoids the selection bias that occurs when cases are drawn from a single hospital. African Americans represented 21% of our study population (because of oversampling), which is substantially higher than other studies on this topic. We were able to evaluate a large number of covariates for possible confounding, and all recognized important confounders of the relationship between alcohol and CRC were controlled for in our multivariate analysis.
The limitations of this study are primarily related to potential misclassification of the exposure. Alcohol intake was self-reported as recorded on the nurse-administered study questionnaire. It is well known that self-reported alcohol intake is subject to under or misreporting, and as with all retrospective studies, there is potential for recall bias. Because of the manner in which the study questionnaire was structured, we obtained average daily consumption, and could not account for patterns of use such as binge drinking or changes in drinking patterns over time, or for lifetime alcohol consumption. Furthermore, the definitions of moderate and heavy alcohol use may not apply equally to all participants because of body weight and/or genetic differences, although we did adjust for elevated body mass index in our analyses. Another issue with all observational trials of alcohol intake relates to the fact that abstainers may be systematically different from nonabstainers. The nondrinker category may contain former drinkers including recovered alcoholics, and those who stop drinking because of illness or concern for medication interactions. Moderate drinking also may be a marker of higher socioeconomic status, a healthier lifestyle, or both. For this reason, we evaluated several different measures of socioeconomic status for confounding (education level, insurance status, and income). Nevertheless, we cannot exclude the possibility that drinking in moderation is so tightly coupled to other cancer-protective behaviors that multivariate analysis was unable to completely isolate the effect of alcohol intake alone, and that residual confounding exists. Although we did not find statistically significant results in some smaller subgroups (eg, heavy drinkers of wine and liquor) this may be because of a lack of statistical power; thus, these results should be interpreted with caution.
CONCLUSION
Moderate alcohol intake, especially wine, was inversely associated with distal colorectal cancer in this populationbased case-control study. These results should not be interpreted as an endorsement of alcohol, because excessive alcohol consumption has been clearly linked to other health problems such as accidents and injuries, 43 teratogenicity, 44 cardiomyopathy, 45 pancreatitis, 46 liver disease, 47 and premature death, 48 and there are some individuals for whom no amount of alcohol is safe (eg, people with alcoholism or cirrhosis). Nevertheless, our findings add to the growing body of literature suggesting that drinking alcohol in moderation may have a beneficial role for some cancers, including rectal cancer.
